中文版 | English

在结果中检索

HFCAS OpenIR
（本次检索基于用户作品认领结果）

浏览/检索结果: 共2条，第1-2条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study 期刊论文
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 卷号: 25
作者:  Wang Xueqian;  Zhang Ying;  Hou Wei;  Wang Yingtian;  Zheng Jiabin;  Li Jie;  Lin Lizhu;  Jiang Yilan;  Wang Shenyu;  Xie Ying;  Zhang Hongliang;  Shu Qijin;  Li Ping;  Wang Wei;  You Jianliang;  Li Ge;  Liu Jie;  Fan Huiting;  Zhang Meiying;  Lin Hongsheng
收藏  |  浏览/下载：25/0  |  提交时间：2020/10/26
CELL LUNG-CANCER  ADJUVANT CHEMOTHERAPY  Chinese medicine  non-small cell lung cancer  postoperative care  cohort study  disease-free survival  
Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139, 期号: 无, 页码: 674-697
作者:  Chen, Yongfei;  Wu, Jiaxin;  Wang, Aoli;  Qi, Ziping;  Jiang, Taoshan;  Chen, Cheng;  Zou, Fengming;  Hu, Chen;  Wang, Wei;  Wu, Hong;  Hu, Zhenquan;  Wang, Wenchao;  Wang, Beilei;  Wang, Li;  Ren, Tao;  Zhang, Shanchun;  Liu, Qingsong;  Liu, Jing
浏览  |  Adobe PDF(12656Kb)  |  收藏  |  浏览/下载：21282/11467  |  提交时间：2018/08/17
Egfr  Alk  Dual Kinase Inhibitor  Non-small Cell Lung Cancer